S. Blum

Discipline

Psychologie (4) Science politique (2) Economies et finances (2) Droit (2) Sociologie (1) Anthropologie biologique (1)

Type de document

Articles (27) Recensions (4)

Type de document

Autres (1) Documents audiovisuels (1)

Co-auteur

Auteur

Date

Date

Source

Source

Mot-clé

Human beings (16) Patients (13) Patients (13) survie (10) Survival (10) Treatment (8) Older people (8) risque (6) Acute myeloid leukemia (6) Risk (6) Bone marrow (6) temps (durée) (5) maladie (5) taux (5) Protein-tyrosine kinase (5) Time (5) Therapeutics (5) Leukemia (5) cohorte (5) maladie (5) puits (4) thérapie (4) âge (4) adulte (4) Diagnosis (4) Chemotherapy (4) Myelodysplastic syndromes (4) Prognosis (4) Months (4) Diagnosis (4)

Mot-clé

Paris (1) Dynamics (1) Development (1) Surgery (1) Employment (1) Diseases (1) Discovery and exploration (1) Acquisition (1) Year (1) Wrestling (1) Urology (1) Ureters (1) Organs (Anatomy) (1) National parks and reserves (1) Kidneys--Calculi (1) Kidneys (1) Goblets (1) Bowls (Tableware) (1) Bladder (1) Technique (1) Vocational guidance (1) Movements (1) Transplanting (1) Patients (1) Medicine (1) Occupations (1) Transplantation (1) Lucha libre (1) Uréteres (1) Vejiga (1)

Documents écrit par S. Blum (27) | parle de S. Blum (2)

Effets secondaires des inhibiteurs de tyrosine kinase dans la leucémie myéloïde chronique [Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia]
J. Dereme et al. (15 nov. 2023)
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
R. Sarkis et al.
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
V. Papadopoulou et al. (2023)
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
A. Coukos et al. (31 août 2022)
Neisseria meningitidis in peripheral blood smear.
N. Dewarrat et al.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
A. Ségot et al. (1 mars 2022)
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
G. Stalder et al.
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript.
S. Voruz et al. (20 déc. 2021)
Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy.
M.R. Robinson et al. (28 sept. 2021)
EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT.
S. Blum et al.
Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment.
J. Tratwal et al.
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
A. Kuendgen et al.
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
G. Huls et al. (22 sept. 2020)
COVID-19, une approche polyphonique.
S. Blum et al. (29 avr. 2020)
Acute leukemia in the time of COVID-19.
M. Gavillet et al. (26 mars 2020)
Successful desensitization to pomalidomide in a patient with POEMS syndrome with delayed-type hypersensitivity to immunomodulatory imid drugs.
F. Grandoni et al.
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
T. Silzle et al. (9 août 2019)
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
S. Voruz et al.
Risk factors for heart failure hospitalizations among patients with atrial fibrillation.
L. Eggimann et al. (2018)
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
S. Voruz et al.
Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation.
S. Blum et al. (30 juin 2017)
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations.
S. Blum et al. (2016)
Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine.
M. Gavillet et al.
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.
M. Mallo et al. (2011)
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
J. Neukirchen et al.

next
Le scanner avec reconstruction tridimensionnelle de surface (3DS) en urologie. Technique. Résultats.
Jacques Hubert
62-1-13. — Le test P. N. Corman (L.). — Le test P. N. Une dynamique nouvelle de la projection. Paris, P.U.F
E. J.-P. Valin (1962)